Microbot Medical Inc. Issues 600,000 Shares, 374,167 Shares in Preferred Option Exercises, and Grants New Series J Options in Recent Transactions

Reuters10-04
<a href="https://laohu8.com/S/MBOT">Microbot Medical Inc</a>. Issues 600,000 Shares, 374,167 Shares in Preferred Option Exercises, and Grants New Series J Options in Recent Transactions

**Microbot Medical Inc. Announces Recent Share Transactions** Microbot Medical Inc. reported that, on September 29, 2025, a holder exercised 600,000 series H preferred investment options for 600,000 shares of common stock at $2.10 per share, and received 600,000 new series J preferred investment options. The same holder is expected to exercise an additional 1,324,488 options by October 15, 2025. Additionally, on September 23, 2025, another holder exercised 374,167 preferred investment options at prices between $1.875 and $2.6625 per share, generating approximately $896,000 in gross proceeds. H.C. Wainwright & Co., LLC also received 30,000 preferred investment options as part of these transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016866), on October 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment